FDA CDC News2 years ago
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease
Today, the U.S. Food and Drug Administration approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare...
